Cargando…
Combination of Circulating Tumor Cells with Serum Carcinoembryonic Antigen Enhances Clinical Prediction of Non-Small Cell Lung Cancer
Circulating tumor cells (CTCs) have emerged as a potential biomarker in the diagnosis, prognosis, treatment, and surveillance of lung cancer. However, CTC detection is not only costly, but its sensitivity is also low, thus limiting its usage and the collection of robust data regarding the significan...
Autores principales: | Chen, Xi, Wang, Xu, He, Hua, Liu, Ziling, Hu, Ji-Fan, Li, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440620/ https://www.ncbi.nlm.nih.gov/pubmed/25996878 http://dx.doi.org/10.1371/journal.pone.0126276 |
Ejemplares similares
-
Circulating tumor cell levels and carcinoembryonic antigen: An improved diagnostic method for lung adenocarcinoma
por: Ding, Cheng, et al.
Publicado: (2018) -
The Significance of Serum Carcinoembryonic Antigen in Lung Adenocarcinoma
por: Kim, Jae Jun, et al.
Publicado: (2015) -
Carcinoembryonic Antigen in Whole Serum
por: MacSween, J. M., et al.
Publicado: (1972) -
Serum carcinoembryonic antigen elevation in benign lung diseases
por: Yang, Yi, et al.
Publicado: (2021) -
Clinical implication of tissue carcinoembryonic antigen expression in association with serum carcinoembryonic antigen in colorectal cancer
por: Aldilaijan, Abdulmohsin Fawzi, et al.
Publicado: (2023)